Symptoms and course of psychosis after methamphetamine abuse: One-year follow-up of a case

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 12, Issue 5, 2010, Pages

  Shariat, Seyed Vahid ^a   Elahi, Adele ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BIPERIDEN; HALOPERIDOL; METHAMPHETAMINE; RISPERIDONE;

ADULT; AUDITORY HALLUCINATION; CASE REPORT; DISEASE COURSE; DOSE RESPONSE; DRUG ABUSE; DRUG DEPENDENCE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; FOLLOW UP; HUMAN; INSOMNIA; LETTER; MALE; PATIENT ASSESSMENT; PERSECUTORY DELUSION; PSYCHOSIS; SUICIDE ATTEMPT; TREATMENT OUTCOME;

EID: 78650592850     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088//PCC.10l00959gry     Document Type: Letter

References (12)

1. United Nations Office on Drugs and Crimes. World Drug Report 2009. Vienna, Austria: United Nations Office on Drugs and Crimes; 2009.
2. Drug Control Headquarters. Drug Control in 2008: Annual Report and Rapid Situation Assessment. Tehran, Iran: Drug Control Headquarters; 2009.
3. Shariat SV, Elahi A, Ahmadzad Asl M. Symptoms and course of psychotic symptoms in methamphetamine induced psychosis: a case series. Ninth Annual Meeting of the Iranian Psychiatric Association; Tehran, Iran; 2009.
4. Iwanami A, Kanamori R, Suga I, et al. Reduced attention-related negative potentials in methamphetamine psychosis. J Nerv Ment Dis. 1995;183(11):693-697. PubMed doi:10.1097/00005053-199511000-00004
5. Sato M, Numachi Y, Hamamura T. Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull. 1992;18(1):115-122. PubMed
6. Yui K, Goto K, Ikemoto S, et al. Methamphetamine psychosis: spontaneous recurrence of paranoid-hallucinatory states and monoamine neurotransmitter function. J Clin Psychopharmacol. 1997;17(1):34-43. PubMed doi:10.1097/00004714-199702000-00007
7. Zorick TS, Rad D, Rim C, et al. An overview of methamphetamine-induced psychotic syndromes. Addict Disord Their Treat. 2008;7(3):143-156. doi:10.1097/ADT.0b013e318066d5e0
8. Ujike H, Sato M. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann N Y Acad Sci. 2004;1025(1):279-287. PubMed doi:10.1196/annals.1316.035
9. Yui K, Ikemoto S, Goto K, et al. Susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis. J Clin Psychopharmacol. 2003;23(5):525-528. PubMed doi:10.1097/01.jcp.0000088919.02635.d7
10. Wada K, Fukui S. Residual symptoms in methamphetamine psychosis. J Ment Health (Ichikawa). 1991;37:161-168.
11. Iwanami A, Sugiyama A, Kuroki N, et al. Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan: a preliminary report. Acta Psychiatr Scand. 1994;89(6):428-432. PubMed doi:10.1111/j.1600-0447.1994.tb01541.x
12. Bousman CA, Glatt SJ, Everall IP, et al. Genetic association studies of methamphetamine use disorders: a systematic review and synthesis. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(8):1025-1049. PubMed doi:10.1002/ajmg.b.30936